Compare RLYB & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLYB | RGS |
|---|---|---|
| Founded | 2018 | 1922 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.9M | 72.0M |
| IPO Year | 2021 | 1994 |
| Metric | RLYB | RGS |
|---|---|---|
| Price | $15.68 | $29.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 312.9K | 7.2K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.24 |
| EPS | N/A | ★ 0.89 |
| Revenue | $858,000.00 | ★ $210,134,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $32.36 |
| Revenue Growth | ★ 43.00 | 3.52 |
| 52 Week Low | $0.27 | $18.23 |
| 52 Week High | $16.00 | $31.50 |
| Indicator | RLYB | RGS |
|---|---|---|
| Relative Strength Index (RSI) | 74.89 | 63.86 |
| Support Level | $0.55 | $28.97 |
| Resistance Level | $15.31 | $30.59 |
| Average True Range (ATR) | 0.69 | 1.03 |
| MACD | 0.05 | 0.06 |
| Stochastic Oscillator | 71.13 | 100.00 |
Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.